Rezolute Announces Pricing of Approximately $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Transaction led by Frazier Life Sciences with participation from new and existing funds
Transaction led by Frazier Life Sciences with participation from new and existing funds